Interaction between human serum albumin and cholesterol-grafted polyglutamate as the potential carriers of protein drugs

[1]  Nicholas A. Peppas,et al.  Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery , 2018, Acta pharmaceutica Sinica. B.

[2]  Chen Jiang,et al.  Biomacromolecules as carriers in drug delivery and tissue engineering , 2017, Acta pharmaceutica Sinica. B.

[3]  Yongzhuo Huang,et al.  Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides , 2016, Acta pharmaceutica Sinica. B.

[4]  M. Shoichet,et al.  Designer protein delivery: From natural to engineered affinity-controlled release systems , 2016, Science.

[5]  Venkatareddy Nadithe,et al.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.

[6]  Yanbin Huang,et al.  Effects of PEG molecular weight on its interaction with albumin , 2015, Chinese Journal of Polymer Science.

[7]  Yanbin Huang,et al.  Fibril aggregates of the poly(glutamic acid)–drug conjugate , 2015 .

[8]  M. Novo,et al.  Fluorescence emission of pyrene in surfactant solutions. , 2015, Advances in colloid and interface science.

[9]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[10]  H. Cottet,et al.  Size and charge characterization of polymeric drug delivery systems by Taylor dispersion analysis and capillary electrophoresis , 2013, Analytical and Bioanalytical Chemistry.

[11]  Xiangrong Song,et al.  Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier. , 2013, International journal of pharmaceutics.

[12]  Christina Graf,et al.  Multivalency as a chemical organization and action principle. , 2012, Angewandte Chemie.

[13]  Wim E Hennink,et al.  Hydrogels for protein delivery. , 2012, Chemical reviews.

[14]  K. Akiyoshi,et al.  Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. , 2010, Chemical record.

[15]  M. Sung,et al.  Synthesis of an amphiphilic poly(gamma-glutamic acid)-cholesterol conjugate and its application as an artificial chaperone. , 2010, Journal of microbiology and biotechnology.

[16]  David E. Golan,et al.  Protein therapeutics: a summary and pharmacological classification , 2008, Nature Reviews Drug Discovery.

[17]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[18]  Wolfgang Schärtl,et al.  Light Scattering from Polymer Solutions and Nanoparticle Dispersions , 2007 .

[19]  K. Lundstrom,et al.  Review on Medusa®:a polymer-based sustained release technology for protein and peptide drugs , 2007, Expert opinion on drug delivery.

[20]  A. Theriault,et al.  Human serum albumin and its structural variants mediate cholesterol efflux from cultured endothelial cells. , 2003, Biochimica et biophysica acta.

[21]  M A Tracy,et al.  Development and Scale‐up of a Microsphere Protein Delivery System , 1998, Biotechnology progress.

[22]  Shigeru Deguchi,et al.  Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles , 1993 .

[23]  D. Gibson,et al.  Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection , 1984, Clinical pharmacology and therapeutics.

[24]  D. Bonderman,et al.  A water-soluble cholesterol derivative for use in augmenting serum control materials. , 1978, Clinical chemistry.